Atherosclerosis
Volume 195, Issue 2 , Pages 287-296 , December 2007

Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy

  • Yoichiro Takahashi

      Affiliations

    • Second Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondoh, Akita 010-8543, Japan
    • ,
  • Hiroyuki Watanabe

      Affiliations

    • Second Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondoh, Akita 010-8543, Japan
    • ,
  • Manabu Murakami

      Affiliations

    • Department of Pharmacology, Akita University School of Medicine, Akita, Japan
    • ,
  • Takayoshi Ohba

      Affiliations

    • Second Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondoh, Akita 010-8543, Japan
    • ,
  • Milena Radovanovic

      Affiliations

    • Second Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondoh, Akita 010-8543, Japan
    • ,
  • Kyoichi Ono

      Affiliations

    • Department of Pharmacology, Akita University School of Medicine, Akita, Japan
    • ,
  • Toshihiko Iijima

      Affiliations

    • Department of Pharmacology, Akita University School of Medicine, Akita, Japan
    • ,
  • Hiroshi Ito

      Affiliations

    • Second Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondoh, Akita 010-8543, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 18 884 6110.

Received 1 September 2006 ,Revised 20 December 2006 ,Accepted 29 December 2006.

References 

  1. Touyz R, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639–672
  2. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res. 1982;51:280–289
  3. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal. 2005;7:1302–1314
  4. Eguchi S, Numaguchi K, Iwasaki H, et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem. 1998;273:8890–8896
  5. Schmitz U, Ishida T, Ishida M, et al. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res. 1998;82:1272–1278
  6. Lipskaia L, Lompre AM. Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell. 2004;96:55–68
  7. Gallois A, Bueb JL, Tschirhart E. Effect of SK&F 96365 on extracellular Ca2+-dependent O2 production in neutrophil-like HL-60 cells. Eur J Pharmacol. 1998;361:293–298
  8. Shimoda LA, Sham JS, Shimoda TH, Sylvester JT. L-type Ca2+ channels, resting [Ca2+]i, and ET-1-induced responses in chronically hypoxic pulmonary myocytes. Am J Physiol Lung Cell Mol Physiol. 2000;279:L884–L894
  9. Golovina VA, Platoshyn O, Bailey CL, et al. Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol. 2001;280:H746–H755
  10. Abritton NL, Oancea E, Kuhn MA, Meyer T. Source of nuclear calcium signals. Proc Natl Acad Sci USA. 1995;91:12458–12462
  11. Albert AP, Large WA. Store-operated Ca2+-permeable non-selective cation channels in smooth muscle cells. Cell Calcium. 2003;33:345–356
  12. Mori Y, Wakamori M, Miyakawa T, et al. Transient receptor potential 1 regulates capacitative Ca2+ entry and Ca2+ release from endoplasmic reticulum in B lymphocytes. J Exp Med. 2002;195:673–681
  13. Parekh AB, Putney JW. Store-operated calcium channels. Physiol Rev. 2005;85:757–810
  14. Chen J, Barritt GJ. Evidence that TRPC1 (transient receptor potential canonical 1) forms a Ca2+-permeable channel linked to the regulation of cell volume in liver cells obtained using small interfering RNA targeted against TRPC1. Biochem J. 2003;15:327–336
  15. Watanabe H, Vriens J, Prenen J, et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424:434–438
  16. Murakami M, Ohba T, Xu F, et al. Genomic organization and functional analysis of murine PKD2L1. J Biol Chem. 2005;280:5626–5635
  17. Xu SZ, Beech DJ. TrpC1 is a membrane-spanning subunit of store-operated Ca2+ channels in native vascular smooth muscle cells. Circ Res. 2001;88:84–87
  18. Moissac M, Mustapha S, Greenberg AH, Kirshenbaum L. Bcl-2 activates the transcription factor NF-κB through the degradation of the cytoplasmic inhibitor IκB. J Biol Chem. 1998;273:23946–23951
  19. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element “decoy” against nuclear factor-κB binding site prevents myocardial infarction. Nature Med. 1997;3:894–899
  20. He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL. A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2. J Biol Chem. 2005;280:10997–11006
  21. Bootman MD, Collins TJ, Mackenzie L, et al. 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J. 2002;10:1145–1150
  22. Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2004;286:848–858
  23. Paria BC, Malik AB, Kwiatek AM, et al. Tumor necrosis factor-alpha induces nuclear factor-κB dependent TRPC1 expression in endothelial cells. J Biol Chem. 2003;278:37195–37203
  24. Zahradka P, Werner JP, Buhay S, et al. NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J Mol Cell Cardiol. 2002;34:1609–1621
  25. Woolfolk EA, Eguchi S, Ohtsu H, et al. Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2005;289:C1286–C1294
  26. Frank GD, Saito S, Motley ED, et al. Requirement of Ca2+ and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2. Mol Endocrinol. 2002;16:367–377
  27. Zhang S, Yuan JX, Barrett KE, Dong H. Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol. 2005;288:C245–C252
  28. Funakoshi Y, Ichiki T, Takeda K, et al. Critical role of cAMP-response element-binding protein for Angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 2002;277:18710–18717
  29. Pulver RA, Rose-Curtis P, Roe MW, Wellman GC, Lounsbury KM. Store-operated Ca2+ entry activates the CREB transcription factor in vascular smooth muscle. Circ Res. 2004;94:1351–1358
  30. Pulver-Kaste RA, Barlow CA, Bond J, et al. Ca2+ source-dependent transcription of CRE-containing genes in VSMC. Am J Heart Circ Physiol. 2006;291:97–105
  31. Zagranichnaya TK, Wu X, Villereal ML. Endogenous TRPC1, TRPC3, and TRPC7 proteins combine to form native store-operated channels in HEK-293 cells. J Biol Chem. 2005;280:29559–29569
  32. Beech DJ, Muraki K, Flemming R. Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP. J Physiol. 2004;559:685–706
  33. Bergdahl A, Gomez MF, Wihlborg AK, et al. Plasticity of TRPC expression in arterial smooth muscle: correlation with store-operated Ca2+ entry. Am J Physiol Cell Physiol. 2005;288:C872–C880
  34. Kumar B, Dreja K, Shah S, et al. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res. 2006;98:557–563
  35. Mehrhof FB, Schmidt-Ullrich R, Dietz R, Scheidereit C. Regulation of vascular smooth muscle cell proliferation: role of NF-κB revisited. Circ Res. 2005;96:958–964
  36. Wolfgang D, Eva-Maria S, Klaudia M, et al. Countervailing effects of rapamycin (sirolimus) on nuclear factor-κB activities in neointimal and medial smooth muscle cells. Atherosclerosis. 2006;186:321–330
  37. Sasu S, Beasley D. Essential roles of IκB kinases and ß in serum- and IL-1-induced human VSMC proliferation. Am J Phys. 2000;278:1823–1831
  38. Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB. J Biol Chem. 2000;275:883–889

PII: S0021-9150(07)00037-8

doi: 10.1016/j.atherosclerosis.2006.12.033

Atherosclerosis
Volume 195, Issue 2 , Pages 287-296 , December 2007

Article Tools

* Image Usage & Resolution